The FITC‐labelled aptamer against EV marker (CD63) or FITC‐labelled aptamer against cancer biomarker (HER2) was utilised to detect EVs from three different types of solid cancers, each spiked into the plasma from six individual subjects as illustrated in Figure 5a,c. This evidence concerns the gene ERBB2 and cancer.